Pain started 1 week ago associated with N/V and decreased PO intake since that time.
Compared to the previous tracing ectopy is resolved.
[**2195-4-22**] 06:15AM [**Month/Day/Year 3143**] WBC-10.7 RBC-2.19* Hgb-7.2* Hct-22.3* MCV-102* MCH-33.1* MCHC-32.5 RDW-19.7* Plt Ct-333 [**2195-4-21**] 06:35AM [**Month/Day/Year 3143**] WBC-11.3* RBC-2.22* Hgb-7.3* Hct-22.7* MCV-102* MCH-32.7* MCHC-32.1 RDW-19.4* Plt Ct-347 [**2195-4-20**] 05:50AM [**Month/Day/Year 3143**] WBC-13.1* RBC-2.35* Hgb-7.6* Hct-23.6* MCV-101* MCH-32.4* MCHC-32.2 RDW-18.2* Plt Ct-389 [**2195-4-19**] 07:25AM [**Month/Day/Year 3143**] WBC-11.5* RBC-2.45* Hgb-8.2* Hct-24.5* MCV-100* MCH-33.7* MCHC-33.7 RDW-17.5* Plt Ct-387 [**2195-4-18**] 07:00AM [**Year/Month/Day 3143**] WBC-12.3* RBC-2.52* Hgb-8.1* Hct-25.3* MCV-100* MCH-32.0 MCHC-31.9 RDW-16.7* Plt Ct-391 [**2195-4-17**] 06:10AM [**Year/Month/Day 3143**] WBC-12.6* RBC-2.41* Hgb-7.7* Hct-23.8* MCV-99* MCH-31.9 MCHC-32.3 RDW-16.2* Plt Ct-371 [**2195-4-16**] 09:55AM [**Year/Month/Day 3143**] WBC-17.2* RBC-2.77* Hgb-8.9* Hct-27.4* MCV-99* MCH-32.0 MCHC-32.4 RDW-15.8* Plt Ct-450* [**2195-4-22**] 06:15AM [**Month/Day/Year 3143**] WBC-10.7 RBC-2.19* Hgb-7.2* Hct-22.3* MCV-102* MCH-33.1* MCHC-32.5 RDW-19.7* Plt Ct-333 [**2195-4-21**] 06:35AM [**Month/Day/Year 3143**] WBC-11.3* RBC-2.22* Hgb-7.3* Hct-22.7* MCV-102* MCH-32.7* MCHC-32.1 RDW-19.4* Plt Ct-347 [**2195-4-20**] 05:50AM [**Month/Day/Year 3143**] WBC-13.1* RBC-2.35* Hgb-7.6* Hct-23.6* MCV-101* MCH-32.4* MCHC-32.2 RDW-18.2* Plt Ct-389 [**2195-4-19**] 07:25AM [**Month/Day/Year 3143**] WBC-11.5* RBC-2.45* Hgb-8.2* Hct-24.5* MCV-100* MCH-33.7* MCHC-33.7 RDW-17.5* Plt Ct-387 [**2195-4-18**] 07:00AM [**Year/Month/Day 3143**] WBC-12.3* RBC-2.52* Hgb-8.1* Hct-25.3* MCV-100* MCH-32.0 MCHC-31.9 RDW-16.7* Plt Ct-391 [**2195-4-17**] 06:10AM [**Year/Month/Day 3143**] WBC-12.6* RBC-2.41* Hgb-7.7* Hct-23.8* MCV-99* MCH-31.9 MCHC-32.3 RDW-16.2* Plt Ct-371 [**2195-4-16**] 09:55AM [**Year/Month/Day 3143**] WBC-17.2* RBC-2.77* Hgb-8.9* Hct-27.4* MCV-99* MCH-32.0 MCHC-32.4 RDW-15.8* Plt Ct-450* [**2195-4-14**] 06:45AM [**Year/Month/Day 3143**] WBC-17.0* RBC-2.91* Hgb-9.2* Hct-29.4* MCV-101* MCH-31.7 MCHC-31.3 RDW-15.2 Plt Ct-379 [**2195-4-13**] 05:00AM [**Year/Month/Day 3143**] WBC-16.3* RBC-2.87* Hgb-9.1* Hct-29.2* MCV-102* MCH-31.7 MCHC-31.1 RDW-15.0 Plt Ct-386 [**2195-4-12**] 03:20PM [**Year/Month/Day 3143**] WBC-25.4*# RBC-3.33* Hgb-10.5* Hct-34.2* MCV-103* MCH-31.7 MCHC-30.8* RDW-14.9 Plt Ct-423 [**2195-4-15**] 06:30AM [**Year/Month/Day 3143**] Neuts-89* Bands-1 Lymphs-5* Monos-2 Eos-0 Baso-1 Atyps-0 Metas-2* Myelos-0 [**2195-4-22**] 06:15AM [**Month/Day/Year 3143**] Plt Ct-333 [**2195-4-22**] 06:15AM [**Month/Day/Year 3143**] Plt Ct-333 [**2195-4-21**] 06:35AM [**Month/Day/Year 3143**] Plt Ct-347 [**2195-4-22**] 06:15AM [**Month/Day/Year 3143**] Glucose-93 UreaN-16 Creat-1.1 Na-140 K-3.9 Cl-108 HCO3-25 AnGap-11 [**2195-4-21**] 06:35AM [**Month/Day/Year 3143**] Glucose-78 UreaN-18 Creat-1.1 Na-141 K-4.2 Cl-110* HCO3-24 AnGap-11 [**2195-4-20**] 05:50AM [**Month/Day/Year 3143**] Glucose-75 UreaN-22* Creat-1.1 Na-140 K-3.9 Cl-108 HCO3-24 AnGap-12 [**2195-4-19**] 07:25AM [**Month/Day/Year 3143**] Glucose-74 UreaN-24* Creat-1.3* Na-138 K-3.9 Cl-108 HCO3-25 AnGap-9 [**2195-4-17**] 06:10AM [**Year/Month/Day 3143**] Glucose-78 UreaN-30* Creat-1.5* Na-140 K-3.5 Cl-109* HCO3-20* AnGap-15 [**2195-4-16**] 06:40AM [**Year/Month/Day 3143**] Glucose-86 UreaN-39* Creat-2.2* Na-141 K-3.9 Cl-111* HCO3-19* AnGap-15 [**2195-4-15**] 06:30AM [**Year/Month/Day 3143**] Glucose-81 UreaN-36* Creat-2.0* Na-143 K-4.0 Cl-109* HCO3-24 AnGap-14 [**2195-4-14**] 06:45AM [**Year/Month/Day 3143**] Glucose-75 UreaN-24* Creat-1.1 Na-145 K-3.9 Cl-111* HCO3-25 AnGap-13 [**2195-4-22**] 06:15AM [**Month/Day/Year 3143**] ALT-42* AST-40 AlkPhos-240* Amylase-105* TotBili-0.6 [**2195-4-21**] 06:35AM [**Month/Day/Year 3143**] ALT-49* AST-57* AlkPhos-263* Amylase-107* TotBili-0.7 [**2195-4-20**] 05:50AM [**Month/Day/Year 3143**] ALT-59* AST-53* LD(LDH)-278* AlkPhos-279* Amylase-123* TotBili-0.7 [**2195-4-19**] 07:25AM [**Month/Day/Year 3143**] ALT-71* AST-67* LD(LDH)-263* AlkPhos-283* TotBili-0.6 [**2195-4-18**] 07:00AM [**Year/Month/Day 3143**] ALT-97* AST-119* AlkPhos-327* Amylase-121* TotBili-0.6 [**2195-4-17**] 06:10AM [**Year/Month/Day 3143**] ALT-101* AST-182* AlkPhos-253* Amylase-111* TotBili-0.8 [**2195-4-12**] 04:00AM [**Year/Month/Day 3143**] ALT-45* AST-45* AlkPhos-176* TotBili-1.0 [**2195-4-11**] 02:06AM [**Year/Month/Day 3143**] ALT-42* AST-56* AlkPhos-148* Amylase-260* TotBili-0.8 [**2195-4-10**] 09:46AM [**Year/Month/Day 3143**] ALT-48* AST-48* AlkPhos-159* TotBili-1.0 DirBili-0.6* IndBili-0.4 [**2195-4-21**] 06:35AM [**Month/Day/Year 3143**] Lipase-48 [**2195-4-20**] 05:50AM [**Month/Day/Year 3143**] Lipase-88* [**2195-4-19**] 07:25AM [**Month/Day/Year 3143**] Lipase-76* [**2195-4-18**] 07:00AM [**Year/Month/Day 3143**] Lipase-90* [**2195-4-17**] 06:10AM [**Year/Month/Day 3143**] Lipase-58 [**2195-4-11**] 02:06AM [**Year/Month/Day 3143**] Lipase-198* [**2195-4-10**] 09:46AM [**Year/Month/Day 3143**] Lipase-76* [**2195-4-22**] 06:15AM [**Month/Day/Year 3143**] Calcium-7.7* Phos-2.9 Mg-1.9 [**2195-4-21**] 06:35AM [**Month/Day/Year 3143**] Calcium-8.2* Phos-3.5 Mg-2.1 [**2195-4-20**] 05:50AM [**Month/Day/Year 3143**] Calcium-7.9* Phos-2.9 Mg-1.7  [**2195-4-14**]:  x-ray hands:  IMPRESSION: Severe multi-joint osteoarthritis.
Upon admission was made NPO, given intravenous fluids, and had [**Doctor Last Name **] work done which showed an elevated lipase and white [**Doctor Last Name **] cell count.
Imaging studies of the abdomen showed common bile duct stone.
She underwent an ERCP on [**4-10**] where she had a sphincterotomy and placement of a stent.
She did have anx-ray taken of her hands which did show osteo-arthitis and lesions suggestive of tophaceous gout.
[**Month/Day (4) 2225**] was consulted and recommendations were made for her management with subsequent follow-up.
During the course of her hospitalization, she did have an elevation in her creatinine up to 2-2.2 and her medications were reviewed as a potential source.
On HOD #8, she reported flank pain and was found to have a worsening of her liver function tests and a elevation in her white [**Month/Day (4) **] cell count.
GI was consulted and recommended a repeat ERCP.
On HOD # 12 she underwent an ERCP which showed multiple large stones and a biliary stent was placed.
Over the last few days, her liver function tests have improved and her white [**Month/Day (4) **] cell count has normalized.
A urine culture did show yeast and she was started on a 4 day course of fluconazole.
Her vital signs are stable and she is afebrile.
Her hematocrit is 22.3 and her creatinine has decreased to 1.1.
Of note:  her HCTZ, k-lor, and atacand have not been resumed related to her gout occurrence and normalized [**Name10 (NameIs) **] pressure.
Medications on Admission: atenolol 75mg [**Hospital1 **], klor-10 daily, lansoprazole 30mg QD, vitamin D 400U daily, atacand 16mg [**Hospital1 **], folic acid 1mg daily, felodipine ER 5mg daily, ASA 325mg daily, HCTZ 25mg daily, lipitor 10mg daily, ambien 10mg daily   Discharge Medications: 1. pantoprazole 40 mg Tablet, Delayed Release (E.C.)
3. atenolol 25 mg Tablet Sig: Three (3) Tablet PO BID (2 times a day): hold for [**Hospital1 **] pressure <110, hr <60.
6. felodipine 5 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day: hold for [**Hospital1 **] pressure <110, hr <60.
You can schedule this appointment by calling # [**Telephone/Fax (1) 600**]  Please follow up with Dr. [**Last Name (STitle) **] about repeat ERCP in [**3-13**] weeks.
